Threats and responses: a qualitative study on the early postoperative ambulation experiences of older patients with kinesiophobia after total hip arthroplasty in Western China

威胁与应对:一项关于中国西部地区患有运动恐惧症的老年患者全髋关节置换术后早期下地活动体验的定性研究

阅读:4

Abstract

OBJECTIVE: To understand the authentic early postoperative ambulation experiences of older patients with kinesiophobia following total hip arthroplasty, with the aim of developing early rehabilitation intervention programs for this group. METHODS: This qualitative study employed purposive sampling to recruit 23 patients with kinesiophobia following total hip arthroplasty. Data were collected through semi-structured interviews, and the transcribed texts were analyzed, categorized, and thematically refined using framework analysis. RESULTS: Patients assessed early postoperative ambulation through two main dimensions: threats and responses, which were further categorized into seven themes. The threat assessment included perceived severity (pain and risk of re-injury), susceptibility, internal rewards (self-satisfaction and internal burden), and external rewards (social support and external burden). The response assessment included response efficacy (questioning the effectiveness of activities and being influenced by other patients’ experiences), self-efficacy (lack of trust in their physical condition, negative impact of social support, and lack of accurate understanding of rehabilitation information), and response cost (overcoming inertia, requiring more family support and medical resources). CONCLUSION: It is essential to improve patients’ judgment on the severity and susceptibility of early ambulation, provide as much support as possible, enhance response efficacy and self-efficacy, reduce response costs, and increase motivation and compliance for early ambulation to improve health outcomes for patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。